Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidiabetic agent |
| gptkbp:alternativeName |
meglitinide
|
| gptkbp:associatedWith |
gptkb:repaglinide
gptkb:nateglinide |
| gptkbp:ATCCode |
A10BX
|
| gptkbp:contraindication |
gptkb:diabetic_ketoacidosis
type 1 diabetes |
| gptkbp:discoveredIn |
1990s
|
| gptkbp:drugClass |
meglitinides
|
| gptkbp:eliminationHalfLife |
short
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
stimulates insulin secretion
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
weight gain |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Starlix
|
| gptkbp:bfsLayer |
5
|